Step therapy drug update for Medicare – Effective January 1, 2022
Summary
Effective January 1, 2022, Medicare now requires step therapy documentation for multiple high-cost specialty drugs, meaning providers must document trial and failure of specific lower-cost alternatives before prescribing certain medications. Nine drugs also require new prior authorization in addition to step therapy requirements.
Get alerts when payers change rules like this one
We check Blue Cross Blue Shield of Rhode Island and other payers every day and email you when a change matches your specialty and state.